SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

NCT06422156 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
73
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University Third Hospital

Collaborators